Advanced search
Publication Cover
Neuro-Ophthalmology Volume 34, 2010 - Issue 1
Submit an article Journal homepage
163
Views
27
CrossRef citations to date
0
Altmetric
Review Article

Evidence-based Review of Recommendations for Visual Function Testing in Patients Treated with Vigabatrin

Robert C. SergottWills Eye Institute, Neuro-Ophthalmology Service, Thomas Jefferson University Medical College, Philadelphia, Pennsylvania, USACorrespondence[email protected]
,
James W. WhelessUniversity of Tennessee Health Science Center and LeBonheur Children’s Medical Center Neuroscience Institute, Memphis, Tennessee, USA
,
Michael C. SmithRush Epilepsy Center, Rush University Medical Center, Chicago, Illinois, USA
,
Carol A. WestallDepartment of Ophthalmology and Vision Sciences, University of Toronto and The Hospital for Sick Children, Toronto, Ontario, Canada
,
Randy H. KardonNeuro-Ophthalmology Division, University of Iowa Hospital and Clinics and Veterans Administration, Department of Ophthalmology and Visual Science, University of Iowa, Iowa City, Iowa, USA
,
Anthony ArnoldNeuro-Ophthalmology Division, Jules Stein Eye Institute, University of California Los Angeles, Los Angeles, California, USA
,
Rod ForoozanCullen Eye Institute, Baylor College of Medicine, Houston, Texas, USA
&
Stephen M. SagarLundbeck, Inc., Deerfield, Illinois, USA
 show all
Pages 20-35 | Received 13 Oct 2009, Accepted 17 Dec 2009, Published online: 27 Jan 2010

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Asthik Biswas, Omar Yossofzai, Ajoy Vincent, Cristina Go & Elysa Widjaja. (2020) Vigabatrin-related adverse events for the treatment of epileptic spasms: systematic review and meta-analysis. Expert Review of Neurotherapeutics 20:12, pages 1315-1324.
Read now
Eija Gaily. (2012) Vigabatrin monotherapy for infantile spasms. Expert Review of Neurotherapeutics 12:3, pages 275-286.
Read now
Scott E. Brodie. (2011) Screening for vigabatrin (Sabril®) retinal toxicity in children. Ophthalmic Genetics 32:4, pages 193-195.
Read now
Jason T Lerner, Noriko Salamon & Raman Sankar. (2010) Clinical profile of vigabatrin as monotherapy for treatment of infantile spasms. Neuropsychiatric Disease and Treatment 6, pages 731-740.
Read now

Articles from other publishers (23)

Michael B. Green & Jay S. Duker. (2023) Adverse Ocular Effects of Systemic Medications. Life 13:3, pages 660.
Crossref
Anne D. Strong, Ashley Sturdy, Emily A. McCourt, Rebecca S. Braverman, Jasleen K. Singh, Robert W. Enzenauer & Jennifer L. Jung. (2021) Clinical Utility of Electroretinograms for Evaluating Vigabatrin Toxicity in Children. Journal of Pediatric Ophthalmology & Strabismus 58:3, pages 174-179.
Crossref
Tanyatuth Padungkiatsagul, Loh-Shan Leung & Heather E. Moss. (2020) Retinal Diseases that Can Masquerade as Neurological Causes of Vision Loss. Current Neurology and Neuroscience Reports 20:11.
Crossref
Mary Iype & Kiren George Koshy. (2020) Management of Infantile Spasms: An Updated Review. International Journal of Epilepsy 06:01, pages 04-14.
Crossref
Rod Foroozan. (2018) Vigabatrin: Lessons Learned From the United States Experience. Journal of Neuro-Ophthalmology 38:4, pages 442-450.
Crossref
Kyra Doumlele, Erin Conway, Julie Hedlund, Patricia Tolete & Orrin Devinsky. (2016) A case report on the efficacy of vigabatrin analogue (1 S , 3 S )-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115) in a patient with infantile spasms. Epilepsy & Behavior Case Reports 6, pages 67-69.
Crossref
Scott E. Brodie. 2016. Practical Management of Pediatric Ocular Disorders and Strabismus. Practical Management of Pediatric Ocular Disorders and Strabismus 321 326 .
Prakash Kotagal. (2015) Limiting Retinal Toxicity of Vigabatrin in Children with Infantile Spasms. Epilepsy Currents 15:6, pages 327-329.
Crossref
James D. Akula, Emily R. Noonan, Alessia Di Nardo, Tara L. Favazza, Nan Zhang, Mustafa Sahin, Ronald M. Hansen & Anne B. Fulton. (2015) Vigabatrin can enhance electroretinographic responses in pigmented and albino rats. Documenta Ophthalmologica 131:1, pages 1-11.
Crossref
Carol A. WestallTom WrightFilomeno CorteseAnanthavalli KumarappahO. Carter SneadIIIIIIJoseph R. Buncic. (2014) Vigabatrin retinal toxicity in children with infantile spasms. Neurology 83:24, pages 2262-2268.
Crossref
Andrew L. Lux. (2013) Latest American and European Updates on Infantile Spasms. Current Neurology and Neuroscience Reports 13:3.
Crossref
James W Wheless, Patricia A Gibson, Kari Luther Rosbeck, Maria Hardin, Christine O’Dell, Vicky Whittemore & John M Pellock. (2012) Infantile spasms (West syndrome): update and resources for pediatricians and providers to share with parents. BMC Pediatrics 12:1.
Crossref
Tamara L. Berezina, Albert S. Khouri, M. Douglas Winship & Robert D. Fechtner. (2012) Visual Field and Ocular Safety During Short-Term Vigabatrin Treatment in Cocaine Abusers. American Journal of Ophthalmology 154:2, pages 326-332.e2.
Crossref
Anne Moskowitz, Ronald M. Hansen, Susan E. Eklund & Anne B. Fulton. (2012) Electroretinographic (ERG) responses in pediatric patients using vigabatrin. Documenta Ophthalmologica 124:3, pages 197-209.
Crossref
Hansel M. Greiner, Elizabeth R. Lynch, Steve Fordyce, Karen Agricola, Cynthia Tudor, David Neal Franz & Darcy A. Krueger. (2012) Vigabatrin for Childhood Partial-Onset Epilepsies. Pediatric Neurology 46:2, pages 83-88.
Crossref
W. D. Shields & J. M. Pellock. (2011) Vigabatrin 35 years later - from mechanism of action to benefit-risk considerations. Acta Neurologica Scandinavica 124, pages 1-4.
Crossref
J. M. Pellock. (2011) Balancing clinical benefits of vigabatrin with its associated risk of vision loss. Acta Neurologica Scandinavica 124, pages 83-91.
Crossref
G. T. Plant & R. C. Sergott. (2011) Understanding and interpreting vision safety issues with vigabatrin therapy. Acta Neurologica Scandinavica 124, pages 57-71.
Crossref
R. C. Sergott & C. A. Westall. (2011) Primer on visual field testing, electroretinography, and other visual assessments for patients treated with vigabatrin. Acta Neurologica Scandinavica 124, pages 48-56.
Crossref
John M. Pellock, Edward Faught, Robert C. Sergott, W. Donald Shields, Gregory A. Burkhart, Gregory L. Krauss, Rod Foroozan, David L. Wesche & Mark A. Weinberg. (2011) Registry initiated to characterize vision loss associated with vigabatrin therapy. Epilepsy & Behavior 22:4, pages 710-717.
Crossref
Robert C. Sergott, Richard M. Bittman, Erin M. Christen & Stephen M. Sagar. (2010) Vigabatrin-induced peripheral visual field defects in patients with refractory partial epilepsy. Epilepsy Research 92:2-3, pages 170-176.
Crossref
. (2010) Current World Literature. Current Opinion in Ophthalmology 21:6, pages 495-501.
Crossref
Robert C Sergott. (2010) Recommendations for visual evaluations of patients treated with vigabatrin. Current Opinion in Ophthalmology 21:6, pages 442-446.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.